All Stories

  1. Beyond PD-1: Expanding the Landscape of Immune Checkpoint Targets in Cancer Therapy

    Article • Current Drug Targets, September 2026, Bentham Science Publishers

    Ankush Kumar, ROHIT BHATIA, Vishakha S.

  2. In Silico ADMET Studies, Molecular Docking and Molecular Dynamics Simulation of Thiadiazole Derivatives for the Identification of Putative HsaA Monooxygenase Inhibitors

    Article • Current Medicinal Chemistry, March 2026, Bentham Science Publishers

    KETKI RANI, Vishakha S., Ankush Kumar, Dr Monica gulati, Dr Pranay Wal, Mr Rajeev K Singla, Raghwendra Waghmode

  3. An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021)

    Article • Anti-Cancer Agents in Medicinal Chemistry, May 2024, Bentham Science Publishers

    Mr Balak Das Kurmi, Vishakha S., Dr ANKIT JAIN, Navneesh N, Preeti Patel Patel

  4. Current Trends in the Development of EGFR Inhibitors as Promising Anticancer Agents: Sar and Synthetic Studies from (2010-2020)

    Article • Current Organic Chemistry, January 2023, Bentham Science Publishers

    Mr Balak Das Kurmi, Simranpreet Kaur Wahan , Vishakha S., SITANSHU MONDAL, Preeti Patel Patel